Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females
Abstract: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are increasingly recognized as a common cause of drug-induced erythrocytosis. SGLT2 inhibitor–induced erythropoiesis may increase blood viscosity and precipitate thromboembolism, particularly in patients with preexisting erythrocytosis. We...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925002290 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|